Gain Therapeutics, Inc (GANX) insider trading
Every open-market stock purchase and sale by Gain Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Khalid Islam (Chair), $49.9K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent GANX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 24, 2026 | Gianluca Fuggetta (Officer) | Bought (not open market) | — |
| Mar 24, 2026 | Gene Mack (CEO) | Bought (not open market) | — |
Who's trading GANX
- Gene Mack, CEO: other filings, last Mar 24, 2026
- Gianluca Fuggetta, Officer: other filings, last Mar 24, 2026
Get free alerts when an insider at Gain Therapeutics, Inc files a new trade →